Kei Kohno

1.3k total citations
57 papers, 777 citations indexed

About

Kei Kohno is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Kei Kohno has authored 57 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pathology and Forensic Medicine, 32 papers in Oncology and 17 papers in Immunology. Recurrent topics in Kei Kohno's work include Lymphoma Diagnosis and Treatment (36 papers), Viral-associated cancers and disorders (23 papers) and CNS Lymphoma Diagnosis and Treatment (13 papers). Kei Kohno is often cited by papers focused on Lymphoma Diagnosis and Treatment (36 papers), Viral-associated cancers and disorders (23 papers) and CNS Lymphoma Diagnosis and Treatment (13 papers). Kei Kohno collaborates with scholars based in Japan, Egypt and Thailand. Kei Kohno's co-authors include Shigeo Nakamura, Akira Satou, Seiichi Kato, Ayako Sakakibara, Yuka Suzuki, Masato Nakaguro, Eri Ishikawa, Naoko Asano, Kazuyuki Shimada and Taishi Takahara and has published in prestigious journals such as PLoS ONE, The American Journal of Surgical Pathology and Human Pathology.

In The Last Decade

Kei Kohno

56 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kei Kohno Japan 16 463 409 146 142 115 57 777
Roos J. Leguit Netherlands 19 214 0.5× 209 0.5× 101 0.7× 135 1.0× 121 1.1× 43 887
Deborah J. Chute United States 19 319 0.7× 119 0.3× 66 0.5× 30 0.2× 91 0.8× 77 1.1k
Alexandra E. Kovach United States 13 216 0.5× 255 0.6× 60 0.4× 146 1.0× 25 0.2× 61 826
Magda Zanelli Italy 16 338 0.7× 282 0.7× 109 0.7× 91 0.6× 21 0.2× 127 845
Eric Burks United States 10 91 0.2× 72 0.2× 106 0.7× 45 0.3× 89 0.8× 46 603
Jacob R. Bledsoe United States 13 339 0.7× 177 0.4× 84 0.6× 28 0.2× 46 0.4× 47 731
Matthew G. Fleming United States 12 184 0.4× 305 0.7× 137 0.9× 28 0.2× 58 0.5× 29 715
Feig Sa United States 19 226 0.5× 361 0.9× 40 0.3× 111 0.8× 103 0.9× 55 955
Georgia Karayannopoulou Greece 19 361 0.8× 85 0.2× 27 0.2× 82 0.6× 36 0.3× 67 1.0k
Sajid Mushtaq Pakistan 13 237 0.5× 111 0.3× 33 0.2× 17 0.1× 86 0.7× 86 602

Countries citing papers authored by Kei Kohno

Since Specialization
Citations

This map shows the geographic impact of Kei Kohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Kohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Kohno more than expected).

Fields of papers citing papers by Kei Kohno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kei Kohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Kohno. The network helps show where Kei Kohno may publish in the future.

Co-authorship network of co-authors of Kei Kohno

This figure shows the co-authorship network connecting the top 25 collaborators of Kei Kohno. A scholar is included among the top collaborators of Kei Kohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Kohno. Kei Kohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyoshi, Hiroaki, Mai Takeuchi, Kohta Miyawaki, et al.. (2024). Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma. Pathology - Research and Practice. 254. 155117–155117. 2 indexed citations
2.
Tanaka, Ken, Hiroaki Miyoshi, Keisuke Kawamoto, et al.. (2023). Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor. Pathology. 56(1). 81–91. 2 indexed citations
3.
Takeuchi, Mai, Hiroaki Miyoshi, Yuichiro Semba, et al.. (2023). Digital spatial profiling of CD4+ T cells in classic Hodgkin lymphoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(2). 255–260. 3 indexed citations
4.
Yoshimura, Takuro, Hiroaki Miyoshi, Joji Shimono, et al.. (2022). CD37 expression in follicular lymphoma. Annals of Hematology. 101(5). 1067–1075. 7 indexed citations
6.
Miyoshi, Hiroaki, Keisuke Kawamoto, Mai Takeuchi, et al.. (2021). Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation. Pathology. 54(4). 442–448. 6 indexed citations
7.
Arakawa, Fumiko, Hiroaki Miyoshi, Noriaki Yoshida, et al.. (2021). Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma. Cancer Medicine. 10(19). 6786–6794. 4 indexed citations
9.
Takahara, Taishi, Yuka Suzuki, Kei Kohno, et al.. (2020). Histiocytic and dendritic cell neoplasms: Reappraisal of a Japanese series based on t(14;18) and neoplastic PD‐L1 expression. Pathology International. 71(1). 24–32. 6 indexed citations
10.
Karube, Kennosuke, et al.. (2020). Co‐occurrence of EBV‐positive classic Hodgkin lymphoma and B‐cell lymphomas of different clonal origins: A case report and literature review. Pathology International. 70(11). 893–898. 7 indexed citations
11.
Sakakibara, Ayako, Yuichiro Inagaki, Yu Sakai, et al.. (2019). Divergence and heterogeneity of neoplastic PD‐L1 expression: Two autopsy case reports of intravascular large B‐cell lymphoma. Pathology International. 69(3). 148–154. 16 indexed citations
12.
Satou, Akira, Tetsuya Tabata, Hiroaki Miyoshi, et al.. (2019). Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases. Modern Pathology. 32(8). 1135–1146. 20 indexed citations
13.
Kohno, Kei, Akira Satou, Ayako Sakakibara, et al.. (2018). Comparison of Epstein–Barr virus‐positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan. Histopathology. 72(7). 1115–1127. 43 indexed citations
14.
Koike, Hiroshi, Yoshihiro Nishida, Kei Kohno, et al.. (2018). Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study. Human Pathology. 84. 155–163. 21 indexed citations
17.
Morimoto, Ryota, Kei Kohno, Akinori Sawamura, et al.. (2018). 免疫チェックポイント阻害剤ニボルマブによる遅発性劇症心筋炎【JST・京大機械翻訳】. Canadian Journal of Cardiology. 34(6). 1–812. 1 indexed citations
18.
Ishikawa, Eri, Tsutomu Tanaka, Kazuyuki Shimada, et al.. (2018). A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B‐cell lymphoma in the rituximab era. Cancer Medicine. 7(7). 3510–3520. 26 indexed citations
19.
Narimatsu, Hiroto, Kei Kohno, Ikuko Suzuki, et al.. (2014). Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists. Journal of Blood Medicine. 5. 31–31. 4 indexed citations
20.
Kohno, Kei, et al.. (1997). Effect of fentanyl on heart rate variability during mechanical ventilation. Journal of Anesthesia. 11(4). 270–276. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026